Analytical Data
-
基因名
UBXD7
- Application
-
别名
KIAA0794; UBX domain-containing Protein 7; UBXD7; UBXN7; UBXN7_HUMAN
-
种属
Human
-
表达系统
E. coli
-
标签
His tag N-Terminus
-
纯度
Greater than 90% as determined by SDS-PAGE.
-
蛋白编号
O94888
-
表达区间
2-489 aa
-
氨基酸序列
AAHGGSAAS SALKGLIQQF TTITGASESV GKHMLEACNN NLEMAVTMFL DGGGIAEEPS TSSASVSTVR PHTEEEVRAP IPQKQEILVE PEPLFGAPKR RRPARSIFDG FRDFQTETIR QEQELRNGGA IDKKLTTLAD LFRPPIDLMH KGSFETAKEC GQMQNKWLMI NIQNVQDFAC QCLNRDVWSN EAVKNIIREH FIFWQVYHDS EEGQRYIQFY KLGDFPYVSI LDPRTGQKLV EWHQLDVSSF LDQVTGFLGE HGQLDGLSSS PPKKCARSES LIDASEDSQL EAAIRASLQE THFDSTQTKQ DSRSDEESES ELFSGSEEFI SVCGSDEEEE VENLAKSRKS PHKDLGHRKE ENRRPLTEPP VRTDPGTATN HQGLPAVDSE ILEMPPEKAD GVVEGIDVNG PKAQLMLRYP DGKREQITLP EQAKLLALVK HVQSKGYPNE RFELLTNFPR RKLSHLDYDI TLQEAGLCPQ ETVFVQERN
-
分子量
54.8 kDa
-
内毒素
< 1.0 EU per μg protein as determined by the LAL method.
-
性状
Freeze-dried powder
-
缓冲液
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
复溶方法
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- 个性化定制
-
稳定性测试
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
保存条件 & 期限
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
运输条件
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
UBXD7 is a protein that has garnered attention in recent years due to its role in various cellular processes, particularly in the regulation of protein degradation and the immune response. As a member of the UBX domain-containing protein family, UBXD7 is involved in the modulation of the ubiquitin-proteasome system, which is crucial for maintaining cellular homeostasis by tagging damaged or unnecessary proteins for degradation. Research has shown that UBXD7 can interact with several key enzymes and proteins involved in this pathway, influencing processes such as apoptosis and cellular stress responses. Moreover, emerging evidence suggests that UBXD7 may play a significant role in cancer pathogenesis and the development of certain diseases, making it a potential candidate for therapeutic targeting. The recombinant production of UBXD7 facilitates functional studies, allowing researchers to investigate its molecular mechanisms and interactions in greater detail. Understanding the structure-function relationship of UBXD7 could provide insights into its biological significance and its potential as a biomarker or therapeutic target in diseases associated with protein misfolding or dysregulation. Overall, research on UBXD7 not only enhances our understanding of fundamental biological processes but also opens avenues for developing novel strategies in disease management.
